BATS | ETF
The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies).
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 9.76% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 7.88% |
| CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 7.57% |
| TXG | 10X Genomics Inc | Healthcare | Health Information Services | 6.65% |
| ABSI | Absci Corp | Healthcare | Biotechnology | 5.59% |
| PSNL | Personalis Inc | Healthcare | Diagnostics & Research | 5.45% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.71% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 4.68% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 4.66% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.15% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.28% |
| CDNA | CareDx Inc | Healthcare | Diagnostics & Research | 3.20% |
| NTLA | Intellia Therapeutics Inc | Healthcare | Biotechnology | 2.95% |
| RXRX | Recursion Pharmaceuticals Inc | Healthcare | Biotechnology | 2.85% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Diagnostics & Research | 2.75% |
| CMPS | Compass Pathways Plc | Healthcare | Medical Care Facilities | 2.73% |
| SDGR | Schrodinger Inc | Healthcare | Health Information Services | 2.20% |
| NRIX | Nurix Therapeutics Inc | Healthcare | Biotechnology | 2.11% |
| WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.02% |
| BFLY | Butterfly Network Inc | Healthcare | Medical Devices | 2.00% |